Hematocrit drift and outcomes in surgical patients with aneurysmal subarachnoid hemorrhage.
Aneurysm
Hematocrit
Mortality
Subarachnoid hemorrhage
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
04 May 2024
04 May 2024
Historique:
received:
27
02
2024
accepted:
22
04
2024
medline:
5
5
2024
pubmed:
5
5
2024
entrez:
4
5
2024
Statut:
epublish
Résumé
There is a paucity of conclusive evidence regarding the impact of downward drift in hematocrit levels among patients who have undergone surgical clipping for aneurysmal subarachnoid hemorrhage (aSAH). This study endeavors to explore the potential association between hematocrit drift and mortality in this specific patient population. A cohort study was conducted, encompassing adult patients diagnosed with aSAH at a university hospital. The primary endpoint was follow-up mortality. Propensity score matching was employed to align patients based on their baseline characteristics. Discrimination capacity across various models was assessed and compared using net reclassification improvement (NRI). Among the 671 patients with aSAH in the study period, 118 patients (17.6%) experienced an in-hospital hematocrit drift of more than 25%. Following adjustment with multivariate regression analysis, patients with elevated hematocrit drift demonstrated significantly increased odds of mortality (aOR: 2.12, 95% CI: 1.14 to 3.97; P = 0.019). Matching analysis yielded similar results (aOR: 2.07, 95% CI: 1.05 to 4.10; P = 0.036). The inclusion of hematocrit drift significantly improved the NRI (P < 0.0001) for mortality prediction. When in-hospital hematocrit drift was served as a continuous variable, each 10% increase in hematocrit drift corresponded to an adjusted odds ratio of 1.31 (95% CI 1.08-1.61; P = 0.008) for mortality. In conclusion, the findings from this comprehensive cohort study indicate that a downward hematocrit drift exceeding 25% independently predicts mortality in surgical patients with aSAH. These findings underscore the significance of monitoring hematocrit and managing anemia in this patient population.
Sections du résumé
BACKGROUND
BACKGROUND
There is a paucity of conclusive evidence regarding the impact of downward drift in hematocrit levels among patients who have undergone surgical clipping for aneurysmal subarachnoid hemorrhage (aSAH). This study endeavors to explore the potential association between hematocrit drift and mortality in this specific patient population.
METHODS
METHODS
A cohort study was conducted, encompassing adult patients diagnosed with aSAH at a university hospital. The primary endpoint was follow-up mortality. Propensity score matching was employed to align patients based on their baseline characteristics. Discrimination capacity across various models was assessed and compared using net reclassification improvement (NRI).
RESULTS
RESULTS
Among the 671 patients with aSAH in the study period, 118 patients (17.6%) experienced an in-hospital hematocrit drift of more than 25%. Following adjustment with multivariate regression analysis, patients with elevated hematocrit drift demonstrated significantly increased odds of mortality (aOR: 2.12, 95% CI: 1.14 to 3.97; P = 0.019). Matching analysis yielded similar results (aOR: 2.07, 95% CI: 1.05 to 4.10; P = 0.036). The inclusion of hematocrit drift significantly improved the NRI (P < 0.0001) for mortality prediction. When in-hospital hematocrit drift was served as a continuous variable, each 10% increase in hematocrit drift corresponded to an adjusted odds ratio of 1.31 (95% CI 1.08-1.61; P = 0.008) for mortality.
CONCLUSIONS
CONCLUSIONS
In conclusion, the findings from this comprehensive cohort study indicate that a downward hematocrit drift exceeding 25% independently predicts mortality in surgical patients with aSAH. These findings underscore the significance of monitoring hematocrit and managing anemia in this patient population.
Identifiants
pubmed: 38703244
doi: 10.1007/s00701-024-06097-9
pii: 10.1007/s00701-024-06097-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
202Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Références
Badenes R, Oddo M, Suarez JI et al (2017) Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey. Crit Care 21(1):159
doi: 10.1186/s13054-017-1748-4
pubmed: 28623949
pmcid: 5473997
Baron DM, Hochrieser H, Posch M et al (2014) Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 113(3):416–423
doi: 10.1093/bja/aeu098
pubmed: 24829444
Bilotta F, Guerra C, Rosa G (2013) Update on anesthesia for craniotomy. Curr Opin Anaesthesiol 26(5):517–522
doi: 10.1097/01.aco.0000432513.92822.c2
pubmed: 23995058
Boffetta P, Islami F, Vedanthan R et al (2013) A U-shaped relationship between haematocrit and mortality in a large prospective cohort study. Int J Epidemiol 42(2):601–615
doi: 10.1093/ije/dyt013
pubmed: 23569195
pmcid: 3619954
Cable CA, Razavi SA, Roback JD et al (2019) RBC Transfusion Strategies in the ICU: A Concise Review. Crit Care Med 47(11):1637–1644
doi: 10.1097/CCM.0000000000003985
pubmed: 31449062
pmcid: 8319734
Carson JL, Guyatt G, Heddle NM et al (2016) Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 316(19):2025–2035
doi: 10.1001/jama.2016.9185
pubmed: 27732721
Ceulemans A, Pinckaers FME, Postma AA et al (2024) Association between anemia and clinical outcome in acute ischemic stroke patients treated with endovascular treatment. J Stroke 26(1):87–94
doi: 10.5853/jos.2023.01669
pubmed: 38246723
pmcid: 10850445
Chen P, Wang Y, Zhang XH et al (2021) The use of acute normovolemic hemodilution in clipping surgery for aneurysmal subarachnoid hemorrhage. World Neurosurg 148:e209–e217
doi: 10.1016/j.wneu.2020.12.110
pubmed: 33385596
Chittiboina P, Conrad S, McCarthy P et al (2011) The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective. World Neurosurgery 75(5–6):660–664
doi: 10.1016/j.wneu.2011.02.019
pubmed: 21704933
Chittiboina P, Guthikonda B, Wollblad C et al (2011) A computational simulation of the effect of hemodilution on oxygen transport in middle cerebral artery vasospasm. J Cereb Blood Flow Metab 31(11):2209–2217
doi: 10.1038/jcbfm.2011.83
pubmed: 21629259
pmcid: 3210345
Da Silva IRF, Gomes JA, Wachsman A et al (2017) Hematologic counts as predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Crit Care 37:126–129
doi: 10.1016/j.jcrc.2016.09.011
pubmed: 27718411
Dankbaar JW, Slooter AJC, Rinkel GJE et al (2010) Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Critical Care 14(1):R23
doi: 10.1186/cc8886
pubmed: 20175912
pmcid: 2875538
Darkwah Oppong M, Lohrer L, Wrede KH et al (2023) Reevaluation of risk factors for aneurysmal subarachnoid hemorrhage associated epilepsy. J Neurol Sci 444:120519
doi: 10.1016/j.jns.2022.120519
pubmed: 36563606
Deem S, Diringer M, Livesay S et al (2023) Hemodynamic management in the prevention and treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care 39(1):81–90
doi: 10.1007/s12028-023-01738-w
pubmed: 37160848
Desjardins P, Turgeon AF, Tremblay MH et al (2012) Hemoglobin levels and transfusions in neurocritically ill patients: a systematic review of comparative studies. Crit Care 16(2):R54
doi: 10.1186/cc11293
pubmed: 22471943
pmcid: 3681381
Dhar R, Zazulia AR, Derdeyn CP et al (2017) RBC transfusion improves cerebral oxygen delivery in subarachnoid hemorrhage. Crit Care Med 45(4):653–659
doi: 10.1097/CCM.0000000000002266
pubmed: 28169942
pmcid: 5350019
Ekelund A, Reinstrup P, Ryding E et al (2002) Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 144(7):703–12 (discussion 12–3)
doi: 10.1007/s00701-002-0959-9
pubmed: 12181704
Haegens NM, Gathier CS, Horn J et al (2018) Induced hypertension in preventing cerebral infarction in delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 49(11):2630–2636
doi: 10.1161/STROKEAHA.118.022310
pubmed: 30355184
Helenius K, Longford N, Lehtonen L et al (2019) Association of early postnatal transfer and birth outside a tertiary hospital with mortality and severe brain injury in extremely preterm infants: observational cohort study with propensity score matching. BMJ (Clinical research ed) 367:l5678
pubmed: 31619384
Kramer AH, Diringer MN, Suarez JI et al (2011) Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey. Crit Care 15(1):R30
doi: 10.1186/cc9977
pubmed: 21244675
pmcid: 3222066
Kurtz P, Helbok R, Claassen J et al (2016) The effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Neurocrit Care 24(1):118–121
doi: 10.1007/s12028-015-0180-3
pubmed: 26195087
Lee YR, Pustejovsky JE (2023) Comparing random effects models, ordinary least squares, or fixed effects with cluster robust standard errors for cross-classified data. Psychol Methods. https://doi.org/10.1037/met0000538
doi: 10.1037/met0000538
pubmed: 37676165
Lin F, Lu C, Li R et al (2024) The association between hemoglobin concentration and clinical outcomes after aneurysmal subarachnoid hemorrhage: Insights from the LongTEAM registry. CNS Neurosci Ther 30(4):e14506
Liu Y, Li L, Hu H et al (2023) Association between preoperative hematocrit and postoperative 30-day mortality in adult patients with tumor craniotomy. Front Neurol 14:1059401
doi: 10.3389/fneur.2023.1059401
pubmed: 36895901
pmcid: 9990837
Oddo M, Milby A, Chen I et al (2009) Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke 40(4):1275–1281
doi: 10.1161/STROKEAHA.108.527911
pubmed: 19265059
Ouldali N, Toubiana J, Antona D et al (2021) Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 325(9):855–864
doi: 10.1001/jama.2021.0694
pubmed: 33523115
Raposeiras Roubin S, Abu Assi E, Cespon Fernandez M et al (2020) Prevalence and prognostic significance of malnutrition in patients with acute coronary syndrome. J Am Coll Cardiol 76(7):828–840
doi: 10.1016/j.jacc.2020.06.058
pubmed: 32792081
Said M, Gümüs M, Rodemerk J et al (2022) Systematic review and meta-analysis of outcome-relevant anemia in patients with subarachnoid hemorrhage. Sci Rep 12(1):20738
doi: 10.1038/s41598-022-24591-x
pubmed: 36456587
pmcid: 9715711
Sampson TR, Dhar R, Diringer MN (2010) Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care 12(1):4–9
doi: 10.1007/s12028-009-9273-1
pubmed: 19777386
Sen J, Belli A, Albon H et al (2003) Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. The Lancet Neurology 2(10):614–621
doi: 10.1016/S1474-4422(03)00531-3
pubmed: 14505583
Shah AH, Snow R, Wendell LC et al (2023) Association of hemoglobin trend and outcomes in aneurysmal subarachnoid hemorrhage: A single center cohort study. J Clin Neurosci 107:77–83
doi: 10.1016/j.jocn.2022.12.008
pubmed: 36521368
Tibi P, McClure RS, Huang J et al (2021) STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management. Ann Thorac Surg 112(3):981–1004
doi: 10.1016/j.athoracsur.2021.03.033
pubmed: 34217505
TomićMahečić T, Brooks R, Noitz M et al (2022) The limits of acute anemia. J Clin Med 11(18):5279
doi: 10.3390/jcm11185279
Treggiari MM, Deem S (2009) Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care 15(2):83–86
doi: 10.1097/MCC.0b013e32832922d1
pubmed: 19276798
Tykocki T, Kostyra K, Bojanowski K et al (2014) Analysis of the serum components in acute period after subarachnoid hemorrhage. Turk Neurosurg 24(5):672–678
pubmed: 25269035
Zeineddine HA, Honarpisheh P, McBride D et al (2022) Targeting hemoglobin to reduce delayed cerebral ischemia after subarachnoid hemorrhage. Transl Stroke Res 13(5):725–735
doi: 10.1007/s12975-022-00995-9
pubmed: 35157256
pmcid: 9375776